• Return to Headlines

Shares of Dexcom Rise Above Previous 52-Week High

By James Quinn

Shares of Dexcom (NASDAQ:DXCM) traded at a new 52-week high today of $148.56. So far today approximately 125,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares.

DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

Dexcom (NASDAQ:DXCM) is currently priced 44.4% above its average consensus analyst price target of $81.25. The stock should find initial support at its 50-day moving average (MA) of $120.28 and further support at its 200-day MA of $82.68.

In the past 52 weeks, shares of Dexcom have traded between a low of $42.62 and a high of $148.56 and are now at $146.11, which is 243% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.6% while the 200-day MA has risen 1.7%.

SmarTrend recommended that subscribers consider buying shares of Dexcom on August 2nd, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $120.23. Since that recommendation, shares of Dexcom have risen 21.6%. We continue to monitor DXCM for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows dexcom

Ticker(s): DXCM